Skip to content
Review Open access

Pain Mechanisms in Fibromyalgia: An Integrative Narrative Review of Central, Peripheral, Neuroimmune, and Psychobiological Factors

Sep 2026 · Biomedicines · Vol 14 · 0 citations · 114 references
Medicine

TL;DR

Fibromyalgia is best understood as a heterogeneous nociplastic pain syndrome arising from partially overlapping central, peripheral, neuroimmune, autonomic, and psychobiological mechanisms whose relative contribution varies across patients.

Abstract

Background/Objectives: Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, cognitive dysfunction, and multisensory hypersensitivity. It is increasingly conceptualized as a heterogeneous nociplastic pain condition in which altered nociceptive processing interacts with dysfunctional pain regulation, neuroimmune mechanisms, and variable peripheral contributions. This integrative narrative review aims to synthesize current evidence on the major mechanisms underlying pain in fibromyalgia, with particular emphasis on central sensitization, descending pain modulation, neurochemical dysregulation, small-fiber pathology, neuroimmune processes, and psychobiological modulators. Methods: An integrative narrative review was conducted using iterative, mechanism-oriented searches of the biomedical literature, primarily in PubMed/MEDLINE and complemented by targeted bibliographic searches and reference tracking. Research published up to July 2026 was considered, with emphasis on human mechanistic studies, systematic reviews, meta-analyses, and landmark experimental evidence relevant to the major pathophysiological domains of fibromyalgia. Results: Central sensitization and altered nociceptive gain remain prominent mechanisms of pain amplification in fibromyalgia, but they do not fully account for the clinical phenotype. Evidence also supports impaired and heterogeneous descending pain modulation, neurochemical imbalance, neuroimmune activation, autonomic and stress-system dysregulation, and peripheral contributions, including small-fiber pathology in a substantial subgroup of patients. These mechanisms appear to interact rather than operate independently, while cognitive and emotional factors further modulate symptom severity, persistence, and functional impact. Conclusions: Fibromyalgia is best understood as a heterogeneous nociplastic pain syndrome arising from partially overlapping central, peripheral, neuroimmune, autonomic, and psychobiological mechanisms whose relative contribution varies across patients. Recognizing this mechanistic heterogeneity may improve phenotypic stratification, biomarker development, and the design of more individualized, mechanism-informed therapeutic strategies.

Read PDF

Similar papers

Review Sep 2026

Fibromyalgia beyond pain: a multisystemic dysregulation framework.

Fibromyalgia (FM) is a prevalent and highly complex disease associated with a substantial reduction in quality of life and functional capacity, as well as significant use of healthcare resources. It is characterized by widespread pain, fatigue, sleep disturbances, and cognitive symptoms, among other manifestations. The...

M. Serrat, Sergi Estanyol, David Cifre et al. · 0 citations
Review Open access Sep 2026

Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network Organization

Psilocybin should not currently be regarded as an established analgesic, as available evidence supports a biologically plausible but clinically unproven model requiring phenotype-specific randomized trials with active controls, biomarkers, and long-term follow-up.

M. S. Neves, C. T. P. Gusmão, Raimundo Chiyo et al. · 0 citations
Review Open access Sep 2026

Inflammatory Biomarkers in Low Back Pain: Physiological Insights and Implications for Exercise: A Narrative Review

Low back pain is a major cause of disability and is increasingly recognized as a multifactorial condition involving complex inflammatory and neuroimmune mechanisms. Inflammatory biomarkers may provide insight into the biological processes underlying pain persistence and may have potential value for patient stratificati...

Manuela Filipec, Marko Bodrožić, Marinela Jadanec Đurin · 0 citations
Review Open access Sep 2026

Neuroimmune Phenotyping as the Next Frontier in Chronic Pain Medicine for Musculoskeletal Back Pain

Chronic low back pain encompasses heterogeneous mechanical, neuropathic, nociplastic, and myofascial presentations that may reflect distinct neuroimmune mechanisms. We synthesized evidence linking these phenotypes to measurable biological features and clinically relevant treatment strategies. We conducted a structured...

Samer G. Salman, Rohan A. Phadke, Adithya Nair et al. · 0 citations
Review Open access Sep 2026

Neuroplastic mechanisms of chronic pain: Implications and future directions

Chronic pain is now increasingly viewed as aberrant neuroplasticity rather than a protracted expression of peripheral nociception. This review integrates current knowledge through the lens of a peripheral-to-central paradigm, whereby peripheral sensory sensitization contributes to pain initiation, spinal excitation–inh...

Kai-Kai Wang, Yan-Hui He, Jin-Hai Liu et al. · 0 citations
Review Open access Jan 2026

Pathological Mechanisms of Tendinopathy Pain: From Mechanical Overload to Neuroimmune–Vascular Crosstalk

Characterized by localized pain and functional impairment, tendinopathy remains a significant challenge in sports medicine. Traditional models of structural degeneration and inflammation inadequately explain the clinical discordance between tissue damage and pain severity. This review explores the paradigm shift in und...

Chen-Yu He, Ai-Kang Li, Qing-Yi Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.